CD49f Acts as an Inflammation Sensor to Regulate Differentiation, Adhesion, and Migration of Human Mesenchymal Stem Cells

Stem Cells

Volumn 33, Issue 9, 2015, Pages 2798-2810

  Yang, Zhigang ^a   Dong, Ping ^a   Fu, Xin ^a   Li, Qiuchen ^a   Ma, Shize ^b   Wu, Dongying ^b   Kang, Ning ^a   Liu, Xia ^a   Yan, Li ^a   Xiao, Ran ^a  

^a PLASTIC SURGERY HOSPITAL   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Alpha6 Integrin; Mammalian target of rapamycin; Mesenchymal Stem Cells; Tissue transglutaminase; TNFalpha

Indexed keywords

ALPHA6 INTEGRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LAMININ; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BEHAVIOR CHANGE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FETUS; FETUS CELL; GENE SILENCING; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ADULT STEM CELL; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; DRUG EFFECTS; EMBRYONIC STEM CELL; FEMALE; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PREGNANCY;

MAMMALIA;

ADULT; ADULT STEM CELLS; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; EMBRYONIC STEM CELLS; FEMALE; HUMANS; INFLAMMATION; INTEGRIN ALPHA6; MESENCHYMAL STROMAL CELLS; PREGNANCY;

EID: 84940467275     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2063     Document Type: Article

References (61)

1. Wei X, Yang X, Han ZP, et al., Mesenchymal stem cells: A new trend for cell therapy. Acta Pharmacol Sin 2013; 34: 747-754.
2. Dominici M, Le Blanc K, Mueller I, et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
3. Boxall SA, Jones E,. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012; 2012: 975871.
4. Lv FJ, Tuan RS, Cheung KM, et al., Concise review: The surface markers and identity of human mesenchymal stem cells. Stem Cells 2014; 32: 1408-1419.
5. Lee RH, Seo MJ, Pulin AA, et al., The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice. Blood 2009; 113: 816-826.
6. Yu KR, Yang SR, Jung JW, et al., CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells 2012; 30: 876-887.
7. Rodin S, Antonsson L, Niaudet C, et al., Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment. Nat Commun 2014; 5: 3195.
8. Rodin S, Domogatskaya A, Strom S, et al., Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 2010; 28: 611-615.
9. Shen Q, Wang Y, Kokovay E, et al., Adult SVZ stem cells lie in a vascular niche: A quantitative analysis of niche cell-cell interactions. Cell Stem Cell 2008; 3: 289-300.
10. Notta F, Doulatov S, Laurenti E, et al., Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 2011; 333: 218-221.
11. Chen S, Lewallen M, Xie T,. Adhesion in the stem cell niche: Biological roles and regulation. Development 2013; 140: 255-265.
12. Krishnamoorthy S, Honn KV,. Inflammation and disease progression. Cancer Metastasis Rev 2006; 25: 481-491.
13. Licastro F, Candore G, Lio D, et al., Innate immunity and inflammation in ageing: A key for understanding age-related diseases. Immun Ageing 2005; 2: 8.
14. Tang J, Yan H, Zhuang S,. Inflammation and oxidative stress in obesity-related glomerulopathy. Int J Nephrol 2012; 2012: 608397.
15. Tracey KJ, Cerami A,. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993; 9: 317-343.
16. Cenci S, Weitzmann MN, Roggia C, et al., Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 2000; 106: 1229-1237.
17. Fu X, Han B, Cai S, et al., Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factor-alpha and its possible role in wound healing. Wound Repair Regen 2009; 17: 185-191.
18. Ren G, Zhao X, Zhang L, et al., Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 2010; 184: 2321-2328.
19. Xiao Q, Wang SK, Tian H, et al., TNF-alpha increases bone marrow mesenchymal stem cell migration to ischemic tissues. Cell Biochem Biophys 2012; 62: 409-414.
20. Kern S, Eichler H, Stoeve J, et al., Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24: 1294-1301.
21. Fu X, Toh WS, Liu H, et al., Establishment of clinically compliant human embryonic stem cells in an autologous feeder-free system. Tissue Eng Part C Methods 2011; 17: 927-937.
22. Miki T, Marongiu F, Ellis E, et al., Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol 2007;Chapter 1:Unit 1E 3.
23. Baksh D, Yao R, Tuan RS,. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25: 1384-1392.
24. Marthiens V, Kazanis I, Moss L et al. Adhesion molecules in the stem cell niche-More than just staying in shape? J Cell Sci 2010; 123: 1613-1622.
25. Lathia JD, Patton B, Eckley DM, et al., Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. J Comp Neurol 2007; 505: 630-643.
26. Meng Y, Eshghi S, Li YJ, et al., Characterization of integrin engagement during defined human embryonic stem cell culture. FASEB J 2010; 24: 1056-1065.
27. Qian H, Tryggvason K, Jacobsen SE, et al., Contribution of alpha6 integrins to hematopoietic stem and progenitor cell homing to bone marrow and collaboration with alpha4 integrins. Blood 2006; 107: 3503-3510.
28. Stingl J, Eirew P, Ricketson I, et al., Purification and unique properties of mammary epithelial stem cells. Nature 2006; 439: 993-997.
29. Cooper HM, Tamura RN, Quaranta V,. The major laminin receptor of mouse embryonic stem cells is a novel isoform of the alpha 6 beta 1 integrin. J Cell Biol 1991; 115: 843-850.
30. Tamura RN, Cooper HM, Collo G, et al., Cell type-specific integrin variants with alternative alpha chain cytoplasmic domains. Proc Natl Acad Sci USA 1991; 88: 10183-10187.
31. Thorsteinsdottir S, Roelen BA, Freund E, et al., Expression patterns of laminin receptor splice variants alpha 6A beta 1 and alpha 6B beta 1 suggest different roles in mouse development. Dev Dyn 1995; 204: 240-258.
32. Aggarwal BB., Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 2003; 3: 745-756.
33. Tigges U, Boroujerdi A, Welser-Alves JV, et al., TNF-alpha promotes cerebral pericyte remodeling in vitro, via a switch from alpha1 to alpha2 integrins. J Neuroinflammation 2013; 10: 33.
34. Gao B, Saba TM, Tsan MF,. Role of alpha(v)beta(3)-integrin in TNF-alpha-induced endothelial cell migration. Am J Physiol Cell Physiol 2002; 283: C1196-1205.
35. Halfon S, Abramov N, Grinblat B, et al., Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev 2011; 20: 53-66.
36. Yang ZX, Han ZB, Ji YR, et al., CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS One 2013; 8: e59354.
37. Bruunsgaard H, Skinhoj P, Pedersen AN, et al., Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin Exp Immunol 2000; 121: 255-260.
38. Rinaldi N, Barth TF, Weis D, et al., Loss of laminin and of the laminin receptor integrin subunit alpha 6 in situ correlates with cytokine induced down regulation of alpha 6 on fibroblast-like synoviocytes from rheumatoid arthritis. Ann Rheum Dis 1998; 57: 559-565.
39. Siler U, Seiffert M, Puch S, et al., Characterization and functional analysis of laminin isoforms in human bone marrow. Blood 2000; 96: 4194-4203.
40. Pronk CJ, Veiby OP, Bryder D, et al., Tumor necrosis factor restricts hematopoietic stem cell activity in mice: Involvement of two distinct receptors. J Exp Med 2011; 208: 1563-1570.
41. Hara T, Ando K, Tsurumi H, et al., Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia. Eur J Haematol 2004; 73: 10-16.
42. Shi M, Li J, Liao L, et al., Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: Role in homing efficiency in NOD/SCID mice. Haematologica 2007; 92: 897-904.
43. Ziaei R, Ayatollahi M, Yaghobi R, et al., Involvement of TNF-alpha in differential gene expression pattern of CXCR4 on human marrow-derived mesenchymal stem cells. Mol Biol Rep 2014; 41: 1059-1066.
44. Lorand L, Graham RM,. Transglutaminases: Crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4: 140-156.
45. Chhabra A, Verma A, Mehta K,. Tissue transglutaminase promotes or suppresses tumors depending on cell context. Anticancer Res 2009; 29: 1909-1919.
46. Mehta K, Kumar A, Kim HI,. Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer. Biochem Pharmacol 2010; 80: 1921-1929.
47. Kumar A, Hu J, LaVoie HA, et al., Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: Role in cancer cell migration. BMC Cancer 2014; 14: 256.
48. Akimov SS, Belkin AM,. Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 2001; 98: 1567-1576.
49. Houglum K, Buck M, Kim DJ, et al., TNF-alpha inhibits liver collagen-alpha 1(I) gene expression through a tissue-specific regulatory region. Am J Physiol 1998; 274: G840-847.
50. Johnson K, Hashimoto S, Lotz M, et al., Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol 2001; 159: 149-163.
51. Suto N, Ikura K, Sasaki R,. Expression induced by interleukin-6 of tissue-type transglutaminase in human hepatoblastoma HepG2 cells. J Biol Chem 1993; 268: 7469-7473.
52. Carrero R, Cerrada I, Lledo E, et al., IL1beta induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-kappaB. Stem Cell Rev 2012; 8: 905-916.
53. Wang L, Zhao Y, Liu Y, et al., IFN-gamma and TNF-alpha synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFkappaB signaling. Stem Cells 2013; 31: 1383-1395.
54. Castilho RM, Squarize CH, Chodosh LA, et al., mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell 2009; 5: 279-289.
55. Chakkalakal JV, Jones KM, Basson MA, et al., The aged niche disrupts muscle stem cell quiescence. Nature 2012; 490: 355-360.
56. Gan B, DePinho RA,. mTORC1 signaling governs hematopoietic stem cell quiescence. Cell Cycle 2009; 8: 1003-1006.
57. Gharibi B, Farzadi S, Ghuman M, et al., Inhibition of Akt/mTOR attenuates age-related changes in mesenchymal stem cells. Stem Cells 2014; 32: 2256-2266.
58. Sharpless NE, DePinho RA,. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 2007; 8: 703-713.
59. Johnson SC, Rabinovitch PS, Kaeberlein M,. mTOR is a key modulator of ageing and age-related disease. Nature 2013; 493: 338-345.
60. Chen C, Liu Y, Liu Y, et al., mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal 2009; 2: ra75.
61. Yilmaz OH, Katajisto P, Lamming DW, et al., mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake. Nature 2012; 486: 490-495.